Bicycle Therapeutics plc American Depositary Shares (NASDAQ: BCYC) last traded at $4.37, up 3.07% on the session. The quote above updates while this page is open; the figures below are drawn from Bicycle Therapeutics plc American Depositary Shares’s own filings and are restated only when a new one is published.
Bicycle Therapeutics plc American Depositary Shares trades on NASDAQ under the ticker BCYC. Its market capitalisation is $305.09 million.
Valuation measures for Bicycle Therapeutics plc American Depositary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $305.09M |
|---|---|
| Enterprise value | -$108.64M |
| Price / sales | 4.98 |
| Price / book | 0.60 |
| Beta | 1.38 |
Trailing-twelve-month figures tagged in Bicycle Therapeutics plc American Depositary Shares's XBRL filings with the SEC.
| Revenue (TTM) | $61.20M |
|---|---|
| Net income (TTM) | -$190.41M |
| EPS (TTM) | -$2.73 |
| Operating margin | -343.60% |
| Return on equity | -37.32% |
| Cash | $510.05M |
Range and volume for BCYC over the past 52 weeks.
| 52-week high | $9.16 |
|---|---|
| 52-week low | $3.75 |
| Volume | 480.3K |
| Average volume | 425.5K |
| Previous close | $4.24 |
Dividend history for Bicycle Therapeutics plc American Depositary Shares over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.